Screening for distress in patients with primary brain tumor using distress thermometer: a systematic review and meta-analysis.
Screening for distress in patients with primary brain tumor using distress thermometer: a systematic review and meta-analysis.
复制标题
使用痛苦温度计筛查原发性脑肿瘤患者的痛苦：系统评价和荟萃分析
DOI：
10.1186/s12885-018-3990-9
复制
发表时间：
2018-02-02
期刊：
影响因子：
3.8
通讯作者：
Liu Z
中科院分区：
文献类型：
--
作者：
Liu F;Huang J;Zhang L;Fan F;Chen J;Xia K;Liu Z
背景：据报道，由于功能性后遗症和不良预后，原发性脑肿瘤患者的痛苦患病率较高，但不同研究对这种疾病的估计患病率有所不同。痛苦温度计（DT）是广泛使用的痛苦筛查工具，以确定患者的社会心理压力升高。本荟萃分析的目的是总结估计DT仪器筛查的成人原发性脑肿瘤患者的窘迫患病率，以识别脑肿瘤患者的窘迫。方法检索截至2017年8月在PubMed、PsycINFO和Cochrane图书馆发表的研究，并检查相关综述和荟萃分析以寻找符合条件的研究。如果研究发表在同行评议的文献中，并通过“痛苦温度计”评估痛苦程度，那么这些研究就符合条件。采用分层荟萃分析的研究水平特征来估计颅内肿瘤患者的焦虑症状的患病率。通过对所纳入的纵向研究进行二次分析，在不同时间点的随访检查中检测出抑郁水平或症状的患病率。结果12项研究共纳入2145例脑肿瘤患者。8个采用横断面设计，4个采用纵向设计。总体样本的总患病率为38.2%（95%可信区间（CI） 28.7%-47.7%）。DT≥4的总患病率为41.1% (642/1686,95% CI 28.6% ~ 53.5%)， DT≥6的总患病率为29.7% （137/459,95% CI 19.5% ~ 39.9%）。在随访研究中，焦虑症状没有减少（相对增加比：1.02,95% CI,(0.78, 1.35)）。在不同的研究中发现了巨大的异质性，并且没有比较不同的筛选量表。结论颅脑原发性肿瘤患者的高患病率是其面临的巨大挑战。常规筛查和评估脑肿瘤患者的痛苦可能有助于医务工作者制定适当的干预措施，这可能导致更好的生活质量和肿瘤管理。
BackgroundPatients with primary brain tumors are reported to have an elevated level of distress prevalence, due to the functional sequelae and the unfavorable prognosis, but the estimated prevalence of this disorder varies among studies. The Distress Thermometer (DT) is widely used distress screening tools to identify patients suffering from elevated psychosocial distress. The objective of this meta-analysis is to get a summarized estimate of distress prevalence in adult primary brain tumor patients screened by the DT instrument to identify distress in brain tumor patients.MethodWe searched studies published in PubMed, PsycINFO, and Cochrane library through August 2017 and checked related reviews and meta-analyses for eligible studies. Studies were eligible if they were published in the peer-reviewed literature and evaluated distress level by Distress Thermometer. The prevalence of distress symptoms in patients with the intracranial tumor was estimated by study-level characteristics using stratified meta-analysis. The prevalence of distress level or symptoms during the follow-up examination at different time points was detected by secondary analysis of the longitudinal studies included.ResultsTwelve studies including a total of 2145 brain tumor patients were included in this analysis. Eight used a cross-sectional design and four were longitudinal. The pooled prevalence of distress was 38.2% (95% confidence interval (CI) 28.7%–47.7%) for the overall sample. The pooled prevalence of distress DT ≥4 was 41.1% (642/1686, 95% CI 28.6%–53.5%) and the pooled prevalence of distress by DT ≥6 was 29.7% (137/459, 95% CI 19.5%–39.9%). The distress symptom did not decrease in follow-up studies (Relative Increase Ratio:1.02, 95% CI, (0.78, 1.35)). A huge heterogeneity in different studies was detected, and different screening scales were not compared.ConclusionThe high prevalence of distress becomes an enormous challenge for primary brain tumor patients. Routine screening and evaluation of distress in brain tumor patients may assist medical workers to develop proper interventions, which may lead to better quality of life and oncology management.
登录
查看更多内容
DOI：
10.1007/s11524-006-9049-2
发表时间：
2006-05-01
影响因子：
6.6
作者：
McVeigh, Katharine H.;Galea, Sandro;Sederer, Lloyd I.
通讯作者：
Sederer, Lloyd I.
影响因子：
15.9
作者：
Arnold, Staci D.;Forman, Leslie M.;Raynor, Renee H.
通讯作者：
Raynor, Renee H.
影响因子：
11
作者：
Mainio, A;Hakko, H;Räsänen, P
通讯作者：
Räsänen, P
影响因子：
2
作者：
Higgins, JPT;Thompson, SG
通讯作者：
Thompson, SG
影响因子：
6.2
作者：
Jacobsen, PB;Donovan, KA;Holland, JC
通讯作者：
Holland, JC